doi: 10.18178/ijimt.2023.14.3.946
Impact of Lean Tools in the Supply Chain: Pharmaceutical Industry Perspective
- Facultad de Ingeniería y Arquitectura, Universidad de Lima, Peru.
Abstract
The aim of this paper is to identify the impact ofthe application of lean tools in the pharmaceutical supply chain(PSC) through a literature review. Supply chain inefficienciesbefore and during the COVID 19 pandemic, most applied tools,and lean improvements found in the PSC are identified.Databases such as Scopus and Proquest were used to collect thepeer-reviewed articles to be studied. Results show the mostfrequent inefficiencies in the supply chain are found in operatingcosts, scrap rates, delivery times, and drug shortages. Theimprovements identified can be summarized in three factors:cost reduction, time reduction, and improvement in themanagement of activities. The most studied tools are Kaizen,Kanban, Total Quality Management (TQM), and Value StreamMapping (VSM). Literature reveals that lean tools have asignificant impact on quality improvement of information,products and/or services, as well as on the reduction orelimination of activities that do not generate value; in addition,there is little evidence of reduction of unnecessary movements ofworkers. The value of this paper addresses the impact of thepandemic on PSC, describing the versatility that each of thetools had in their role to reduce lean wastes. The versatilityallows to identify which tool may be available according to theneed of the practitioner.
Keywords
- Lean
- pharmaceutical industry
- supply chain
- waste
How to Cite
Sebastián Aguirre-Manrique, Valeria Wong-Lam, and Rafael Chávez-Ugaz, "Impact of Lean Tools in the Supply Chain: Pharmaceutical Industry Perspective," International Journal of Innovation, Management and Technology, vol. 14, no. 3, pp. 108-114, 2023. https://doi.org/10.18178/ijimt.2023.14.3.946
Copyright & License
Copyright © 2023 by the authors. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).